Ahu Demir analyst LADENBURG

Currently out of the existing stock ratings of Ahu Demir, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).

Ahu Demir

Work Performance Price Targets & Ratings Chart

Analyst Ahu Demir, currently employed at LADENBURG, carries an average stock price target met ratio of 16.67% that have a potential upside of 2.44% achieved within 1 days. Previously, Ahu Demir worked at NOBLE CAPITAL.

Ahu Demir’s has documented 14 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on EVAX, Evaxion Biotech AS at 02-Apr-2024.

Wall Street Analyst Ahu Demir

Analyst best performing recommendations are on ONTX (ONCONOVA THERAPEUTICS).
The best stock recommendation documented was for ONTX (ONCONOVA THERAPEUTICS) at 12/22/2020. The price target of $6.9 was fulfilled within 1 day with a profit of $0.47 (7.31%) receiving and performance score of 73.09.

Average potential price target upside

AYLA Ayala Pharmaceuticals  ONTX Onconova Therapeutics EVAX Evaxion Biotech AS

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

16

1 years 8 months 25 days ago

0/1 (0%)

$12 (300.00%)

Buy

1

$0.4 (66.67%)

20

1 years 9 months 6 days ago

1/2 (50%)

$4.66 (64.44%)

67

Buy

1 years 11 months 10 days ago

0/1 (0%)

$9.16 (103.62%)

Buy

6

$5.5 (1100.00%)

24

2 years 3 months 26 days ago

0/2 (0%)

$2 (50.00%)

Buy

12

$11.5 (2300.00%)

22

2 years 3 months 26 days ago

0/2 (0%)

$8 (200.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Ahu Demir is most bullish on?

Potential upside of $5.2 has been obtained for EVAX (EVAXION BIOTECH AS)

What Year was the first public recommendation made by Ahu Demir?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?